Healthia Ltd
ASX:HLA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.79
1.795
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Healthia Ltd
Healthia Ltd
Cost of Revenue
Healthia Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Healthia Ltd
ASX:HLA
|
Cost of Revenue
-AU$20.6m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Cost of Revenue
-AU$1.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Cost of Revenue
-AU$22.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Capitol Health Ltd
ASX:CAJ
|
Cost of Revenue
-AU$16m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-16%
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Cost of Revenue
-AU$119.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Cost of Revenue
-AU$224.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
Healthia Ltd
Glance View
Healthia Ltd. is a holding company engages in the operation and expansion of podiatry and physiotherapy clinics, and Business-to-Business businesses in Australia. The company is headquartered in Bowen Hills, Queensland. The company went IPO on 2018-09-11. The company operates an integrated portfolio of health businesses, which include My FootDr, Allsports Physiotherapy, Extend Rehabilitation, iOrthotics and DBS Medical Supplies. My FootDr Podiatry Clinics has over 103 podiatry clinics and shoe stores that is engaged in footwear retailing. Allsports Physiotherapy provides physiotherapy services throughout Brisbane. Extend Rehabilitation provides therapies for hand and upper arm. Its iOrthotics manufactures orthotic design software, 3D printing and other technologies and provides orthotic solutions for over 100 podiatry clinics in Australia. DBS Medical Supplies provide supplies to podiatrists, hospitals, medical centers, nursing homes and allied health professionals throughout Australia, as well as New Zealand, the South Pacific and Hong Kong. DBS offer a range of products including podiatry equipment, surgical instruments, orthotic materials, clinic consumables and foot and nail care products.
See Also
What is Healthia Ltd's Cost of Revenue?
Cost of Revenue
-20.6m
AUD
Based on the financial report for Jun 30, 2023, Healthia Ltd's Cost of Revenue amounts to -20.6m AUD.
What is Healthia Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-31%
Over the last year, the Cost of Revenue growth was -13%. The average annual Cost of Revenue growth rates for Healthia Ltd have been -44% over the past three years , -31% over the past five years .
You don't have any saved screeners yet
